Search Results - "Barberis, Massimo"

Difficulties and inequities in access to homologous recombination deficiency testing in ovarian cancer patients.

Authors: Barberis, Massimo¹ massimo.barberis@ieo.it

Source: European Journal of Gynaecological Oncology. Jun2024, Vol. 45 Issue 3, p1-3. 3p.

Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards.

Authors: Crimini, Edoardo Repetto, Matteo Tarantino, Paolo et al.

Source: Cancers. Jul2022, Vol. 14 Issue 13, pN.PAG-N.PAG. 18p.

Association between Contrast-Enhanced Computed Tomography Radiomic Features, Genomic Alterations and Prognosis in Advanced Lung Adenocarcinoma Patients.

Authors: Rinaldi, Lisa Guerini Rocco, Elena Spitaleri, Gianluca et al.

Source: Cancers. Sep2023, Vol. 15 Issue 18, p4553. 14p.

A Transcriptomic Analysis of Laryngeal Dysplasia.

Authors: Maffini, Fausto Lepanto, Daniela Chu, Francesco et al.

Source: International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 17, p9685. 20p.

Molecular Profiling of H-MSI/dMMR/for Endometrial Cancer Patients: "New Challenges in Diagnostic Routine Practice".

Authors: Adorisio, Riccardo Troncone, Giancarlo Barberis, Massimo et al.

Source: Journal of Molecular Pathology. Jun2024, Vol. 5 Issue 2, p187-198. 12p.

The Genetic and Immunologic Landscape Underlying the Risk of Malignant Progression in Laryngeal Dysplasia.

Authors: Chu, Francesco Maffini, Fausto Lepanto, Daniela et al.

Source: Cancers. Feb2023, Vol. 15 Issue 4, p1117. 13p.

Diagnostic and Predictive Biomarkers in Lung Cancer.

Authors: Fumagalli, Caterina Barberis, Massimo

Source: Cancers. Jun2021, Vol. 13 Issue 11, p2577. 1p.

Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testing.

Authors: Ranghiero, Alberto Frascarelli, Chiara Cursano, Giulia et al.

Source: Cytopathology. Nov2023, Vol. 34 Issue 6, p519-529. 11p.

Single fraction ablative preoperative radiation treatment for early-stage breast cancer: the CRYSTAL study - a phase I/II clinical trial protocol.

Authors: Zerella, Maria Alessia Zaffaroni, Mattia Ronci, Giuseppe et al.

Source: BMC Cancer. 4/2/2022, Vol. 22 Issue 1, p1-12. 12p.

Author Correction: A role for the immune system in advanced laryngeal cancer.

Authors: Tagliabue, Marta Maffini, Fausto Fumagalli, Caterina et al.

Source: Scientific Reports. 5/3/2021, Vol. 11 Issue 1, p1-1. 1p.

The molecular landscape of breast mucoepidermoid carcinoma.

Authors: Venetis, Konstantinos Sajjadi, Elham Ivanova, Mariia et al.

Source: Cancer Medicine. May2023, Vol. 12 Issue 9, p10725-10737. 13p.

miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response.

Authors: Cuttano, Roberto Colangelo, Tommaso Guarize, Juliana et al.

Source: Journal of Hematology & Oncology. 12/31/2022, Vol. 15 Issue 1, p1-24. 24p.

Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical Outcomes.

Authors: Cella, Chiara Alessandra Spada, Francesca Berruti, Alfredo et al.

Source: Cancers. Sep2022, Vol. 14 Issue 18, pN.PAG-N.PAG. 13p.

Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles.

Authors: Sajjadi, Elham Venetis, Konstantinos Noale, Marianna et al.

Source: Cells (2073-4409). Aug2022, Vol. 11 Issue 15, p2286-2286. 14p.

Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future—Five-Years' Single-Institution Experience of 762 Consecutive Patients.

Authors: Fumagalli, Caterina Betella, Ilaria Rappa, Alessandra et al.

Source: Cancers. Apr2022, Vol. 14 Issue 7, p1638. 16p.

BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories.

Authors: Capoluongo, Ettore La Verde, Nicla Barberis, Massimo et al.

Source: Diagnostics (2075-4418). Dec2019, Vol. 9 Issue 4, p146-146. 1p.

Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K).

Authors: Spitaleri, Gianluca Biffi, Roberto Barberis, Massimo et al.

Source: OncoTargets & Therapy. Aug2015, Vol. 8, p1997-2003. 7p.

Breast Cancer Heterogeneity.

Authors: Fumagalli, Caterina Barberis, Massimo

Source: Diagnostics (2075-4418). Sep2021, Vol. 11 Issue 9, p1555. 1p.

Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2− Breast Cancer.

Authors: Venetis, Konstantinos Pepe, Francesco Munzone, Elisabetta et al.

Source: Cells (2073-4409). Nov2022, Vol. 11 Issue 22, p3545. 13p.

Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center Series.

Authors: Fazio, Nicola Maisonneuve, Patrick Spada, Francesca et al.

Source: Cancers. Oct2022, Vol. 14 Issue 19, p4777. 12p.